JP2002511887A5 - - Google Patents

Download PDF

Info

Publication number
JP2002511887A5
JP2002511887A5 JP1999514596A JP51459699A JP2002511887A5 JP 2002511887 A5 JP2002511887 A5 JP 2002511887A5 JP 1999514596 A JP1999514596 A JP 1999514596A JP 51459699 A JP51459699 A JP 51459699A JP 2002511887 A5 JP2002511887 A5 JP 2002511887A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1999514596A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002511887A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/017618 external-priority patent/WO1999010332A1/en
Publication of JP2002511887A publication Critical patent/JP2002511887A/ja
Publication of JP2002511887A5 publication Critical patent/JP2002511887A5/ja
Ceased legal-status Critical Current

Links

JP51459699A 1997-08-22 1998-08-20 プロスタグランジンエンドペルオキシドhシンターゼ生合成阻害薬 Ceased JP2002511887A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91866197A 1997-08-22 1997-08-22
US08/918,661 1997-08-22
PCT/US1998/017618 WO1999010332A1 (en) 1997-08-22 1998-08-20 Prostaglandin endoperoxide h synthase biosynthesis inhibitors

Publications (2)

Publication Number Publication Date
JP2002511887A JP2002511887A (ja) 2002-04-16
JP2002511887A5 true JP2002511887A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=25440748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51459699A Ceased JP2002511887A (ja) 1997-08-22 1998-08-20 プロスタグランジンエンドペルオキシドhシンターゼ生合成阻害薬

Country Status (10)

Country Link
EP (1) EP1005460B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002511887A (cg-RX-API-DMAC7.html)
AT (1) ATE319691T1 (cg-RX-API-DMAC7.html)
CA (1) CA2294548A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105027T1 (cg-RX-API-DMAC7.html)
DE (1) DE69833774T2 (cg-RX-API-DMAC7.html)
DK (1) DK1005460T3 (cg-RX-API-DMAC7.html)
ES (1) ES2260846T3 (cg-RX-API-DMAC7.html)
PT (1) PT1005460E (cg-RX-API-DMAC7.html)
WO (1) WO1999010332A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
BR9813998A (pt) 1997-11-19 2000-09-26 Kowa Co Novos derivados de piridazina e produtos medicinais contendo os mesmos como ingredientes efetivos
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
PL198503B1 (pl) * 1998-10-27 2008-06-30 Abbott Lab Związki pirydazynonowe, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−3−オン誘導体及びこれを含有する医薬
CO5261556A1 (es) 1999-12-08 2003-03-31 Pharmacia Corp Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP2005535642A (ja) 2002-06-28 2005-11-24 ニトロメッド インコーポレーティッド オキシムおよび/またはヒドラゾンを含有するニトロソ化および/またはニトロシル化シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法
BRPI0408359A (pt) 2003-03-18 2006-03-21 Kowa Co derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmos
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
JPWO2005012259A1 (ja) * 2003-07-30 2007-09-27 興和株式会社 オステオポンチン産生抑制方法
DE102004010207A1 (de) 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
DE102006037478A1 (de) * 2006-08-10 2008-02-14 Merck Patent Gmbh 2-(Heterocyclylbenzyl)-pyridazinonderivate
DE102007025718A1 (de) * 2007-06-01 2008-12-04 Merck Patent Gmbh Pyridazinonderivate
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
WO2018049027A1 (en) 2016-09-07 2018-03-15 Trustees Of Tufts College Combination therapies using immuno-dash inhibitors and pge2 antagonists
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3934436A1 (de) * 1989-06-01 1991-04-18 Thomae Gmbh Dr K 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Similar Documents

Publication Publication Date Title
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2000509912A5 (cg-RX-API-DMAC7.html)
JP2000509635A5 (cg-RX-API-DMAC7.html)
JP2000509942A5 (cg-RX-API-DMAC7.html)
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2001511031A5 (cg-RX-API-DMAC7.html)
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000509587A5 (cg-RX-API-DMAC7.html)
JP2001511214A5 (cg-RX-API-DMAC7.html)
JP2000507369A5 (cg-RX-API-DMAC7.html)
JP2000507433A5 (cg-RX-API-DMAC7.html)
JP2001517221A5 (cg-RX-API-DMAC7.html)
JP2000508866A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508022A5 (cg-RX-API-DMAC7.html)
JP2000508841A5 (cg-RX-API-DMAC7.html)
JP2001527657A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2000509804A5 (cg-RX-API-DMAC7.html)
JP2000509755A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2001524035A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2000509818A5 (cg-RX-API-DMAC7.html)
JP2000509520A5 (cg-RX-API-DMAC7.html)